Skip to content

TFF PHARMACEUTICALS, INC.

CIK 0001733413

← back to feed
Revenue (TTM)
$1.28M
+48.0% YoY Q3 Nov 2024
Net Income (TTM)
−$18.17M
+33.1% YoY Q3 Nov 2024
EPS Diluted (TTM)
−$6.75
+55.3% YoY Q3 Nov 2024
Gross Margin
—
Q3 Nov 2024
Operating Margin
-1,385.4%
Q3 Nov 2024
Net Margin
-1,417.6%
Q3 Nov 2024
Free Cash Flow (TTM)
−$20.44M
Q3 Nov 2024
Cash
$2.6M
Q3 Nov 2024
Total Debt
—
Q3 Nov 2024
Shares Outstanding
4.44M sh
Q3 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings